US Stock MarketDetailed Quotes

enVVeno Medical (NVNO)

Watchlist
  • 9.810
  • -0.490-4.76%
Close May 15 16:00 ET
  • 9.530
  • -0.280-2.85%
Post 16:04 ET
6.55MMarket Cap-0.31P/E (TTM)

enVVeno Medical (NVNO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.41%-3.24M
7.54%-15.57M
32.56%-3.44M
-2.71%-4.39M
4.91%-3.72M
-13.18%-4.02M
10.71%-16.84M
-2.65%-5.11M
-1.50%-4.28M
14.38%-3.91M
Net income from continuing operations
14.52%-3.85M
10.76%-19.47M
40.02%-3.74M
19.55%-4.54M
-35.07%-6.69M
9.80%-4.5M
7.22%-21.82M
-10.27%-6.23M
-12.82%-5.64M
23.45%-4.96M
Operating gains losses
--4K
----
----
----
----
----
----
----
----
----
Depreciation and amortization
1.64%124K
-7.39%489K
-4.10%117K
-6.98%120K
-4.41%130K
-13.48%122K
-3.30%528K
-8.96%122K
-6.52%129K
-1.45%136K
Change In working capital
94.40%-27K
-236.55%-396K
-302.99%-540K
-391.67%-700K
2,982.61%1.33M
-309.57%-482K
147.08%290K
80.88%-134K
180.81%240K
-106.13%-46K
-Change in prepaid assets
27.91%55K
52.86%-33K
-173.63%-67K
58.13%-85K
146.63%76K
-79.02%43K
41.18%-70K
106.82%91K
0.00%-203K
-307.50%-163K
-Change in payables and accrued expense
103.41%15K
-99.86%1K
-170.92%-382K
-199.24%-524K
570.15%1.35M
-500.00%-440K
481.42%698K
78.86%-141K
3,620.00%528K
-76.84%201K
-Change in other current liabilities
-14.12%-97K
-7.69%-364K
-8.33%-91K
-7.06%-91K
-15.48%-97K
0.00%-85K
-7.64%-338K
-7.69%-84K
-7.59%-85K
-7.69%-84K
Cash from discontinued investing activities
Operating cash flow
19.41%-3.24M
7.54%-15.57M
32.56%-3.44M
-2.71%-4.39M
4.91%-3.72M
-13.18%-4.02M
10.71%-16.84M
-2.65%-5.11M
-1.50%-4.28M
14.38%-3.91M
Investing cash flow
Cash flow from continuing investing activities
-46.74%2.77M
1,087.72%15.86M
137.83%4.18M
-41.30%3.65M
-28.97%2.82M
136.62%5.2M
116.97%1.34M
50.07%-11.06M
39.93%6.22M
-43.28%3.97M
Net PPE purchase and sale
----
86.49%-5K
--0
--0
64.29%-5K
--0
-12.12%-37K
0.00%-4K
-200.00%-9K
33.33%-14K
Net investment purchase and sale
-46.74%2.77M
1,056.05%15.86M
137.84%4.18M
-41.39%3.65M
-29.09%2.83M
135.55%5.2M
117.51%1.37M
50.08%-11.05M
40.04%6.23M
-43.25%3.99M
Cash from discontinued investing activities
Investing cash flow
-46.74%2.77M
1,087.72%15.86M
137.83%4.18M
-41.30%3.65M
-28.97%2.82M
136.62%5.2M
116.97%1.34M
50.07%-11.06M
39.93%6.22M
-43.28%3.97M
Financing cash flow
Cash flow from continuing financing activities
-92.50%1.02M
782K
-98.23%241K
0
0
-47.12%13.64M
0
13.59M
0
Net common stock issuance
----
-94.25%782K
--782K
----
----
----
-47.30%13.59M
--0
----
----
Proceeds from stock option exercised by employees
----
423.91%241K
--0
--241K
--0
--0
--46K
--0
--0
--0
Cash from discontinued financing activities
Financing cash flow
----
-92.50%1.02M
--782K
-98.23%241K
--0
--0
-47.12%13.64M
--0
--13.59M
--0
Net cash flow
Beginning cash position
74.74%3.07M
-51.55%1.75M
-91.38%1.54M
-14.12%2.04M
26.92%2.94M
-51.55%1.75M
-20.53%3.62M
262.21%17.92M
-49.51%2.38M
1.80%2.31M
Current changes in cash
-139.56%-468K
170.26%1.31M
109.41%1.52M
-103.22%-500K
-1,453.03%-893K
190.58%1.18M
-99.57%-1.87M
-1,118.78%-16.16M
6,596.12%15.54M
-97.30%66K
End cash Position
-11.58%2.6M
74.74%3.07M
74.74%3.07M
-91.38%1.54M
-14.12%2.04M
26.92%2.94M
-51.55%1.75M
-51.55%1.75M
262.21%17.92M
-49.51%2.38M
Free cash flow
19.41%-3.24M
7.72%-15.57M
32.61%-3.44M
-2.50%-4.39M
5.13%-3.72M
-12.87%-4.02M
10.67%-16.88M
-2.65%-5.11M
-1.64%-4.29M
14.46%-3.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.41%-3.24M7.54%-15.57M32.56%-3.44M-2.71%-4.39M4.91%-3.72M-13.18%-4.02M10.71%-16.84M-2.65%-5.11M-1.50%-4.28M14.38%-3.91M
Net income from continuing operations 14.52%-3.85M10.76%-19.47M40.02%-3.74M19.55%-4.54M-35.07%-6.69M9.80%-4.5M7.22%-21.82M-10.27%-6.23M-12.82%-5.64M23.45%-4.96M
Operating gains losses --4K------------------------------------
Depreciation and amortization 1.64%124K-7.39%489K-4.10%117K-6.98%120K-4.41%130K-13.48%122K-3.30%528K-8.96%122K-6.52%129K-1.45%136K
Change In working capital 94.40%-27K-236.55%-396K-302.99%-540K-391.67%-700K2,982.61%1.33M-309.57%-482K147.08%290K80.88%-134K180.81%240K-106.13%-46K
-Change in prepaid assets 27.91%55K52.86%-33K-173.63%-67K58.13%-85K146.63%76K-79.02%43K41.18%-70K106.82%91K0.00%-203K-307.50%-163K
-Change in payables and accrued expense 103.41%15K-99.86%1K-170.92%-382K-199.24%-524K570.15%1.35M-500.00%-440K481.42%698K78.86%-141K3,620.00%528K-76.84%201K
-Change in other current liabilities -14.12%-97K-7.69%-364K-8.33%-91K-7.06%-91K-15.48%-97K0.00%-85K-7.64%-338K-7.69%-84K-7.59%-85K-7.69%-84K
Cash from discontinued investing activities
Operating cash flow 19.41%-3.24M7.54%-15.57M32.56%-3.44M-2.71%-4.39M4.91%-3.72M-13.18%-4.02M10.71%-16.84M-2.65%-5.11M-1.50%-4.28M14.38%-3.91M
Investing cash flow
Cash flow from continuing investing activities -46.74%2.77M1,087.72%15.86M137.83%4.18M-41.30%3.65M-28.97%2.82M136.62%5.2M116.97%1.34M50.07%-11.06M39.93%6.22M-43.28%3.97M
Net PPE purchase and sale ----86.49%-5K--0--064.29%-5K--0-12.12%-37K0.00%-4K-200.00%-9K33.33%-14K
Net investment purchase and sale -46.74%2.77M1,056.05%15.86M137.84%4.18M-41.39%3.65M-29.09%2.83M135.55%5.2M117.51%1.37M50.08%-11.05M40.04%6.23M-43.25%3.99M
Cash from discontinued investing activities
Investing cash flow -46.74%2.77M1,087.72%15.86M137.83%4.18M-41.30%3.65M-28.97%2.82M136.62%5.2M116.97%1.34M50.07%-11.06M39.93%6.22M-43.28%3.97M
Financing cash flow
Cash flow from continuing financing activities -92.50%1.02M782K-98.23%241K00-47.12%13.64M013.59M0
Net common stock issuance -----94.25%782K--782K-------------47.30%13.59M--0--------
Proceeds from stock option exercised by employees ----423.91%241K--0--241K--0--0--46K--0--0--0
Cash from discontinued financing activities
Financing cash flow -----92.50%1.02M--782K-98.23%241K--0--0-47.12%13.64M--0--13.59M--0
Net cash flow
Beginning cash position 74.74%3.07M-51.55%1.75M-91.38%1.54M-14.12%2.04M26.92%2.94M-51.55%1.75M-20.53%3.62M262.21%17.92M-49.51%2.38M1.80%2.31M
Current changes in cash -139.56%-468K170.26%1.31M109.41%1.52M-103.22%-500K-1,453.03%-893K190.58%1.18M-99.57%-1.87M-1,118.78%-16.16M6,596.12%15.54M-97.30%66K
End cash Position -11.58%2.6M74.74%3.07M74.74%3.07M-91.38%1.54M-14.12%2.04M26.92%2.94M-51.55%1.75M-51.55%1.75M262.21%17.92M-49.51%2.38M
Free cash flow 19.41%-3.24M7.72%-15.57M32.61%-3.44M-2.50%-4.39M5.13%-3.72M-12.87%-4.02M10.67%-16.88M-2.65%-5.11M-1.64%-4.29M14.46%-3.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More